(Q44588111)

4 December 2017

title

Beneficial pleiotropic vascular effects of rosuvastatin in two hypertensive models (English)

1 reference

4 December 2017

1 reference

5

Edward D Frohlich

1 reference

4 December 2017

Dinko Susic

1

1 reference

4 December 2017

Jasmina Varagic

series ordinal

2

1 reference

4 December 2017

Jwari Ahn

series ordinal

3

1 reference

4 December 2017

Michael Slama

series ordinal

4

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Journal of the American College of Cardiology

4 December 2017

published in

1 reference

4 December 2017

volume

42

1 reference

4 December 2017

issue

6

1 reference

4 December 2017

page(s)

1091-1097

1 reference

Statins and vascular protection: a 'radical' view

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

New evidence for beneficial effects of statins unrelated to lipid lowering

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Characterization of endothelial factors involved in the vasodilatory effect of simvastatin in aorta and small mesenteric artery of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Inhibition of LOX-1 by statins may relate to upregulation of eNOS.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Pravastatin attenuates cardiovascular inflammatory and proliferative changes in a rat model of chronic inhibition of nitric oxide synthesis by its cholesterol-lowering independent actions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Clinically relevant differences between the statins: implications for therapeutic selection

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Losartan reduces cardiac mass and improves coronary flow reserve in the spontaneously hypertensive rat

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Pharmacologic agents on cardiovascular mass, coronary dynamics and collagen in aged spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Cardiovascular effects of lovastatin in normotensive and spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Downregulation of angiotensin II type 1 receptor by hydrophobic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Statins and angiotensin II-induced vascular injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Coronary hemodynamics in aging spontaneously hypertensive and normotensive Wistar-Kyoto rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900926-4

7 January 2021

10.1016/S0735-1097(03)00926-4

Identifiers

DOI

1 reference

4 December 2017

1 reference